TL;DR: Tranexamic acid started as a clotting medication for heavy bleeding. Dermatologists noticed something else happening, and now it sits at the center of modern melasma protocols.
Quick answer
Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine. It was developed as an anti-fibrinolytic — a drug to stop excessive bleeding — and used for heavy periods. Dermatologists kept noticing that women taking oral TXA for menorrhagia had their melasma fading. That accidental observation became a serious melasma protocol. Topical 2–5% works on surface PIH and mild melasma; oral TXA (prescription, with a clotting-risk screening) is the stronger option for stubborn melasma and hormone-driven pigmentation. Slow, undramatic, and one of the most useful single additions to a pigmentation routine.
How it works on skin
The mechanism is different from how the brighteners you’ve heard of work.
TXA inhibits plasminogen activation in keratinocytes. That sounds technical, but the consequence is simple: it dampens the inflammatory signaling that tells your melanocytes to crank out pigment. The most stubborn pigmentation — melasma — is driven by exactly this kind of signaling cascade, which is why TXA can move it when other brighteners stall.
It also reduces the UV-triggered pigmentation response, so the post-sun darkening is less intense. And it modulates the vascular component of pigmentation, which matters more than people realize — melasma often has a vessel component you can see under polarized light, and TXA addresses both the pigment and the underlying inflammation feeding the vessels.
Multiple mechanisms in one molecule is why TXA punches above its weight on melasma specifically.
Topical versus oral
Topical TXA at 2–5% is OTC and increasingly common. It’s the right starting point for PIH from acne, sun spots, uneven tone, and mild to moderate melasma. Strong evidence base. Lower potency than oral but zero systemic effect.
Oral TXA, typically 250 mg twice daily for 3–6 months, is prescription only in the US. This is the option for moderate-to-severe melasma, treatment-resistant pigmentation, and hormone-driven cases where you’re already on something like spironolactone. It works faster and harder. The trade-off is a clotting-risk screening before you start, because the drug’s original job was anti-fibrinolytic. Not appropriate if you have a clotting disorder, recent DVT or PE, or some pregnancy circumstances.
Using topical TXA
When. AM or PM, your preference. Stable enough for either.
Where in the routine. Serum slot — after cleansing, before moisturizer.
How much. 2–3% is the well-evidenced range. 5% is on the higher end of what shows up OTC.
Pairing. Excellent with vitamin C, niacinamide, retinoids, and azelaic acid. The strongest pigmentation routines combine several of these:
AM: vitamin C plus niacinamide plus tranexamic acid plus iron-oxide sunscreen.
PM: a retinoid or azelaic acid, with tranexamic acid layered in on alternate nights.
That combined approach beats any single-ingredient routine I’ve seen.
Realistic timelines
PIH: 8 to 12 weeks for visible improvement.
Sun spots: 12 to 16 weeks.
Melasma with the full combined protocol: 12 to 24 weeks, sometimes longer.
Sustained results require ongoing maintenance — this isn’t a “treat and stop” situation.
Daily SPF is non-negotiable. Every unprotected sun exposure undoes pigmentation work, and there’s no version of this where you skip it and the protocol still works.
Who should use it
Anyone with persistent PIH from acne or other inflammation. Melasma patients as part of a multi-ingredient routine. Sun-spot-prone skin. Skin of color, where TXA has a lower risk profile than retinoids alone for pigmentation. Pregnancy melasma — topical TXA is generally considered safe (confirm with your OB); oral is contraindicated. Sensitive skin that can’t tolerate hydroquinone.
Who should avoid
Topical TXA is generally safe with few contraindications. Patch test if you’ve had reactions to other amino-acid derivatives.
Oral TXA is the more cautious conversation. Skip if you have a personal or family history of clotting disorders, a recent DVT or PE, if you’re a smoker over 35 (modestly elevated clotting risk), during pregnancy, on combined oral contraceptives (relative contraindication — discuss with your derm), or with active cancer or recent stroke. Always screened before starting.
What it can’t do
It won’t replace SPF. It won’t fade textural scarring — only flat pigmentation. It won’t treat acne itself, only the marks left behind. And it won’t show overnight results.
It’s a slow steady performer, which is exactly what stubborn pigmentation needs.
Where people get it wrong
Using TXA without SPF. You’re paying for a serum and then undoing it every time you walk outside.
Stopping when skin clears. Pigmentation-prone skin is pigmentation-prone forever. Maintenance is part of the deal.
Stacking TXA with multiple aggressive actives at once. Over-irritation actually reduces effectiveness because inflammation drives more pigmentation. Combine TXA with anti-inflammatory partners (niacinamide, centella) rather than piling on AHAs.
Not asking a derm about oral TXA for stubborn melasma. Many cases that don’t respond to topicals respond well to oral. That conversation needs medical context, but it’s a conversation worth having.
Buying the expensive TXA serum without checking the concentration. The Ordinary, Murad, and several Korean brands offer effective TXA at fraction-of-the-price points.
Why it’s still under-marketed
TXA doesn’t sell well as a marketing story. The mechanism is harder to explain than “brightens skin.” The medical history — clotting drug — confuses consumers. Results are slow and undramatic, which doesn’t fit the “glow in two weeks” framing the industry runs on.
So it stays quiet while quietly outperforming. For pigmentation specifically, adding TXA to a routine is one of the highest-impact changes you can make.
Frequently asked questions
Is topical TXA available OTC? Yes, increasingly so.
Can I use it during pregnancy? Topical: generally yes, with your OB’s okay. Oral: contraindicated.
Will it conflict with my other actives? No known antagonism. Pairs cleanly with vitamin C, niacinamide, retinoids, and azelaic acid.
Is oral TXA dangerous? Used appropriately, with screening, no. It’s a well-established medication. The clotting concern is real and manageable in patients without underlying risk factors.
How does it compare to hydroquinone? Comparable efficacy in several studies, with less risk of long-term issues like ochronosis. TXA is increasingly preferred for chronic management.
Sources
Bala HR et al. Oral tranexamic acid for the treatment of melasma. Dermatologic Surgery, 2018. Kim HJ et al. Efficacy and safety of tranexamic acid in melasma. Annals of Dermatology, 2017.